General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Papatheodoridis GV et al. – The newer anti–HBV agents improve the treatment of HBV both pretransplant and post–transplant. HBV immunoglobulin is still used in combination with an anti–HBV agent for post–transplant prophylaxis. Monoprophylaxis with one of the new anti–HBV agents might be possible, particularly in patients preselected as having a low risk of HBV recurrence, but further data are needed and strategies to ensure compliance must be used.

Related Articles

Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09    Relevance Score: 72%

Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay
Clinical Transplantation, 11/18/09    Relevance Score: 70%

Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study
Digestive and Liver Diseases, 11/16/09    Relevance Score: 70%

Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume
Liver Transplantation, 11/04/09    Relevance Score: 70%

Two-stage liver transplantation: an effective procedure in urgent conditions
Clinical Transplantation, 10/23/09    Relevance Score: 70%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address